Rhodotorula mucilaginosa infection in hematopoietic stem cell transplantation setting, case report.
Infección por Rhodotorula mucilaginosa en trasplante alogénico de progenitores hematopoyéticos, reporte de un caso.
Article Sidebar
PDF (Español (España))
FLIP
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Main Article Content
Infection by Rhodotorula spp. is recognized as an emerging infection in the last two decades especially in immunocompromissed patients. This yeast has been described as not very virulent although it can produce uncomplicated systemic infection in blood or even potentially fatal infections such as endocarditis or ventriculitis. Its isolation is associated with central venous catheters. There are only a few cases reported in recipients of hematopoietic transplantation.
Downloads
Article Details
Lunardi LW, Aquino VR, Zimerman RA, Goldani LZ. Epidemiology and outcome of Rhodotorula fungemia in a tertiary care hospital. Clin Infect Dis. 2006;43(6):e60-3.
Wirth F, Goldani LZ. Epidemiology of Rhodotorula: an emerging pathogen. Interdiscip Perspect Infect Dis. 2012;2012:465717.
Tuon FF, Costa SF. Rhodotorula infection. A systematic review of 128 cases from literature. Rev Iberoem Micol. 2008;25(3):135- 40.
Kiehn TE, Gorey E, Brown AE, Edwards FF, Armstrong D. Sepsis due to Rhodotorula related to use of indwelling central venous cetheters. Clin Infect Dis. 1992;14(4):841-6.
Mori T, Nakamura Y, Kato J, Sugita K, Kamei K, Okamoto S. Fungemia due to Rhodotorula mucilaginosa after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2012;14(1):91-4.
Pascualotto GC, Copetti FA, Meneses CF, Machado AR, Brunetto AL. Infection by Rhodotorula sp. in children receiving treatment for malignant diseases. J Pediatr Hematol Oncol. 2005;27(4):232-3.
Forés R, Ramos A, Orden B, De la Iglesia A, Bautista G, Cabero M, et al. Rhodotorula species fungemia causes low mortality in hematopoietic stem-cell transplantation. A case report and review. Mycoses. 2012;55(3):e158-62.
Ramos A, Cabero M, Orden B. Fungemia por Rhodotorula mucilaginosa. Presentación de dos casos. Rev Esp Quimioter. 2012;25(1):76-8.
Nunes JM, Bizerra FC, Ferreira RC, Colombo AL. Molecular identification, antifungal susceptibility profile and biofilm formation of clinical and environmental Rhodotorula species isolates. Antimicrob Agents Chemother. 2013;57(1):382-9.
Kim HA, Hyun M, Ryu SY. Catheter associated Rhodotorula mucilaginosa fungemia in a immucompetent host. Infect Chemother. 2013;45(3):339-42.
Dieckema DJ, Petroelje B, Messer SA, Hollis RJ, Pfaller MA. Activities of available and investigational antifungal agents against Rhodotorula species. J Clin Microbiol. 2005;43(1):476-8.
Preney L, Théraud M, Guiguen C, Gangneux JP. Experimental evalulation of antifungal and antiseptic agents against Rhodotorula spp. Mycoses. 2003;46(11-12):492-5.
Arendrup MC, Boekhout T, Akova M, Meis JF, Cornely OA, Lortholary O, et al. ESCMID and ECMM joint clinical guideline for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect. 2014;20 Suppl 3:76-98.
García-Suárez J, Gómez-Herrus P, Cuadros JA, Burgaleta C. Epidemiology and outcome of Rhodotorula infection in haematological patients. Mycoses. 2011;54(4):318-24.
Simon MS, Somersan S, Singh HK, Hartman B, Wickes BL, Jenkins SG, et al. Endocarditis caused by Rhodotorula infection. J Clin Microbiol. 2014;52(1):374-8.
